Pleural Effusion, Malignant
Information
- Disease name
- Pleural Effusion, Malignant
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00099541 | Completed | Phase 4 | Non-small Cell Lung Cancer Registry | November 2004 | November 2007 |
| NCT00978939 | Completed | Phase 4 | Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter | August 2009 | October 2013 |
| NCT01670786 | Completed | Phase 4 | Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion | January 2010 | July 2013 |
| NCT02517749 | Completed | N/A | Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management | August 2015 | March 2020 |
| NCT03270215 | Completed | The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion | October 1, 2017 | January 30, 2019 | |
| NCT03272997 | Completed | The Value of PET-CT in Pleural Effusions | October 1, 2017 | January 30, 2019 | |
| NCT03276715 | Completed | Prognostic Factors on Malignant Pleural Effusion | June 1, 2016 | October 1, 2018 | |
| NCT03394105 | Completed | Phase 2 | Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer | July 26, 2016 | June 22, 2018 |
| NCT03597828 | Completed | Respiratory Function of Dexmedetomidine in Patients Undergoing Pleuroscopy | August 5, 2018 | June 30, 2020 | |
| NCT04749602 | Completed | Phase 2 | Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion. | August 10, 2020 | March 1, 2023 |
| NCT06275178 | Not yet recruiting | Medical Thoracoscopy for Diagnosing Unexplained Pleural Effusion: a National Multicenter Retrospective Study | March 20, 2024 | December 31, 2024 | |
| NCT06436807 | Not yet recruiting | PMCF Study of the CE-marked Drainova® ArgentiC Catheter | May 2024 | August 2026 | |
| NCT05693727 | Not yet recruiting | Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion | September 1, 2023 | September 1, 2027 | |
| NCT05461430 | Recruiting | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) | July 15, 2022 | July 2026 | |
| NCT04844827 | Recruiting | Pleural Carcinomatosis Tissue Banking | November 17, 2022 | November 17, 2024 | |
| NCT05268172 | Recruiting | Phase 1 | IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites | December 20, 2022 | December 30, 2025 |
| NCT05910112 | Recruiting | Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention | September 1, 2020 | August 1, 2024 | |
| NCT04684459 | Recruiting | Early Phase 1 | Dual-targeting HER2 and PD-L1 CAR-T for Cancers With Pleural or Peritoneal Metastasis | March 12, 2021 | December 30, 2025 |
| NCT05278975 | Recruiting | Phase 1/Phase 2 | Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma | March 31, 2022 | April 1, 2025 |
| NCT04669223 | Recruiting | N/A | Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion | December 1, 2020 | October 30, 2025 |
| NCT04670562 | Recruiting | Longitudinal Follow up of Patients With Pleural Effusion | March 1, 2021 | December 31, 2025 | |
| NCT02702700 | Terminated | Phase 1 | Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies | January 2016 | August 28, 2018 |
| NCT03325192 | Terminated | N/A | Rapid Pleurodesis Through an Indwelling Pleural Catheter | December 12, 2017 | July 9, 2019 |
| NCT04233359 | Terminated | N/A | A Randomised Study Evaluating Diagnostics of Pleural Effusion Among Patients Suspect of Cancer. | December 20, 2019 | September 24, 2020 |
| NCT00316134 | Terminated | Multiple Biomarkers in Undiagnosed Pleural Effusion | March 2006 | February 2008 | |
| NCT02250118 | Terminated | Phase 1 | Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer | December 9, 2014 | October 17, 2017 |
| NCT02825095 | Unknown status | Early Phase 1 | Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis | August 2016 | August 2017 |
| NCT03319186 | Unknown status | N/A | EDIT Management Feasibility Trial | August 28, 2017 | November 2018 |
| NCT05077111 | Unknown status | Phase 4 | A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia | January 15, 2020 | October 15, 2021 |
| NCT01819363 | Unknown status | Relationship Between Pleural Elastance and Effectiveness of Pleurodesis on Recurrent Malignant Pleural Effusion | February 2012 | January 2016 | |
| NCT02045121 | Unknown status | N/A | Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion Management | January 2014 | May 2015 |
| NCT02805062 | Unknown status | Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy | June 2016 | July 2017 | |
| NCT02407912 | Unknown status | N/A | Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer | March 2015 | March 2020 |
| NCT04254445 | Unknown status | N/A | Use of Guidance Videos to Increase Engagement and Decrease Anxiety in Patients Undergoing Pleural Tap | February 16, 2020 | June 30, 2020 |
| NCT03781908 | Unknown status | Phase 1/Phase 2 | Management of Malignant Pleural Effusion With Indwelling Pleural Catheter Versus Silver Nitrate Pleurodesis | January 1, 2019 | January 2020 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D016066